RANDOMIZED CONTROL TRIALS (RCT)

RANDOMIZED CONTROL TRIALS (RCT)

Randomized control trials are one of the most reliable methods for testing new drugs or therapy. It has become a standard for testing the level of safety and efficacy of an experimental drug that has to be proved by the pharmaceutical companies.


NEED FOR RANDOMIZATION

Randomization helps to avoid the incidence of BIAS. Both subjects and Investigators can influence when the researchers assign subjects to groups at random.

If the scientists are looking to demonstrate the ineffectiveness or potential danger of a certain treatment, they may assign participants who have a higher risk of complication or a lower chance of success to the group receiving the treatment. Researchers must disclose the potential conflict of interest when conducting a clinical trial

ADVANTAGES

1.Comparative 

One treatment is directly compared to another

2.Minimises BIAS

Minimises allocation BIAS and selection BIAS

3. Confounding Factor minimization

Randomisation helps to minimize the unequal distribution of other associated factors in the study groups.

Randomisation makes the groups comparable according to both known factors and other unknown associated factors that may cause distortion.

Blocked randomisation makes groups comparable within known confounding

4.Publishable

Considered the gold standard, more publishable.

DISADVANTAGES

1.Logistics

Validity requires multiple sites which will be difficult to manage.

2.Statistics 

Disadvantage of block randomization is the allocation of participants may be

predictable and results in selection BIAS when the study groups are unmasked.

3.Applicability

Trials which test for efficacy may not widely applicable. Trials which test for effectiveness are larger 

and more expensive.

4.Ethical limitation

ICF is often Impossible

Some research cannot be ethically performed as an RCT.

TAKE AWAY

RCT is gold standard for testing the drug.

The participants are assigned to control and experimental groups randomly by the researcher. Selection BIAS may affect the results in such a way that the researcher or the funding agency is benefited with the scientific outcome of that particular study.

REFERENCE

1. https://www.medicalnewstoday.com/articles/280574

2. https://derangedphysiology.com 

Qa q


By:- 

Venkatesh.N

ClinoSol Student ID: 020/0222


Comments

Anonymous said…
Good work Mr.Venkatesh
Keep going..

Popular Posts